B2B Central

COVID-19 treatment

13 Dec 2021

Cipla cares for life in SA by launching COVID-19 anti-viral medicine

By Staff Writer

Cipla is launching the COVID anti-viral medicine, molnupiravir, in South Africa. This medication is for the treatment of mild-to-moderate COVID-19 in adults. Caring for Life As part of its ethos of “Caring for Life”, Cipla is once again championing equitable access to medication, much like it did during the height of the HIV pandemic, when...
08 Feb 2021

SAHPRA sets the record straight on allowing the controlled compassionate use of Ivermectin

By Staff Writer

SAHPRA has released a statement addressing it decision to allow controlled compassionate use of Ivermectin for the treatment of COVID-19. According to the statement, there is an erroneous notion that SAHPRA “buckled under pressure” as a consequence of the court action brought by, amongst others the Afriforum regarding access to Ivermectin. SAHPRA wishes to state...
08 Jan 2021

SAHPRA condemns import and use of Ivermectin for treatment of COVID-19

By Staff Writer

Despite recent headlines of being Ivermectin being a so-called ‘miracle cure’ for COVID-19, the drug has not been approved by SAHPRA and any attempt to import the drug into SA will be perceived as unlawful. Ivermectin is not indicated nor approved by SAHPRA for use in humans. No evidence There is no confirmatory data on...
01 Jul 2020

New COVID-19 vaccine provides a novel vector

By Staff Writer

Tonix Pharmaceuticals and Southern Research have partnered to create a COVID-19 vaccine based on Tonix’s proprietary horsepox vaccine platform. The use of the horsepox vector will be an important addition to the 234 COVID-19 vaccines currently being developed, as it will add another vector to be used for COVID-19 vaccines and boosters, along with providing...
15 Jun 2020

BioNTech receives €100 million in debt financing for development of COVID-19 vaccine

By Staff Writer

The European Investment Bank and BioNTech have concluded a €100 million debt financing agreement to support the development of BNT162, the company’s COVID-19 vaccine programme. The deal will also allow the company to expand its manufacturing capacity in order to supply the vaccine fast worldwide in response to the pandemic. This will be done at...
22 May 2020

Live microbial strain supplement used in COVID-19 clinical trial

By Staff Writer

ADM and Hospital Sagunto, one the largest medical centres in the Valencia region, are partnering for a clinical trial into the effect of using a food supplement containing live microbial strains to promote gut microbiome balance and help improve health functions related to outcomes for COVID-19 patients in high risk groups. On 18 March Dr...
18 May 2020

New drug to treat COVID-19 is ready for human testing

By Staff Writer

VSY Biotechnology Research Centre has developed a drug for treatment of COVID-19 called TR-C 19. The company is very excited to announce the new drug developed to treat COVID-19 by the VSY Biotechnology R&D team. Studies have shown that TR-C 19 can neutralise the virus isolated under laboratory conditions. Authority approval The drug is now...
14 May 2020

Spartan’s COVID-19 test recall illustrates need for proper screening

By Staff Writer

Azadeh Laffafian PhD Medical Device Analyst at GlobalData comments that proper screening and quality assurance must be done on all potential COVID-19 treatments following the announcement that Spartan Bioscience has recalled its rapid COVID-19 test due to concerns by Health Canada. Laffafian says: “Recall of Spartan’s COVID-19 test is not surprising as extraordinary circumstances have...
27 Mar 2020

Austell offers to donate COVID-19 treatment to SA Department of Health

By Staff Writer

Austell Pharmaceuticals has offered to supply the South African Department of Health with 500 000 tablets of Chloroquine Phosphate free of charge, which has shown to substantially reduce the infection and recovery time of patients with COVID-19. Austell is South Africa’s largest black-owned pharmaceutical company. The South African Health Products Regulatory Authority (SAHPRA) has given approval for...